Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CALL
EPAM Systems
EPAM
$5.54B
| $23.5M | ﹤0.01% |
139,200
+39,000
| +39% | +$8.6M |
|
1602
PUT
Kohl's
KSS
$1.99B
| $23.5M | ﹤0.01% |
2,867,000
+1,337,500
| +87% | +$15.5M |
|
1603
CALL
Ametek
AME
$56.4B
| $23.4M | ﹤0.01% |
136,000
-15,600
| -10% | -$2.84M |
|
1604
CALL
Deutsche Bank
DB
$75.6B
| $23.4M | ﹤0.01% |
979,900
+470,600
| +92% | +$9.87M |
|
1605
CALL
Edison International
EIX
$28.6B
| $23.3M | ﹤0.01% |
396,200
+286,700
| +262% | +$16.5M |
|
1606
CALL
Golar LNG
GLNG
$5.23B
| $23.3M | ﹤0.01% |
613,900
+42,200
| +7% | +$1.65M |
|
1607
CALL
Everest Group
EG
$14.5B
| $23.3M | ﹤0.01% |
64,100
+5,300
| +9% | +$1.87M |
|
1608
PUT
J.M. Smucker
SJM
$13.9B
| $23.3M | ﹤0.01% |
196,600
-9,400
| -5% | -$1.02M |
|
1609
PUT
Natera
NTRA
$48.9B
| $23.3M | ﹤0.01% |
164,600
+39,300
| +31% | +$6.32M |
|
1610
Noble Corp
NE
$7.21B
| $23.2M | ﹤0.01% |
980,980
+28,296
| +3% | +$810K |
|
1611
PUT
Groupon
GRPN
$773M
| $23.2M | ﹤0.01% |
1,238,200
+530,600
| +75% | +$6.72M |
|
1612
Union Pacific
UNP
$186B
| $23.2M | ﹤0.01% |
98,348
-198,232
| -67% | -$47.7M |
|
1613
PUT
2x Long VIX Futures ETF
UVIX
$219M
| $23.2M | ﹤0.01% |
31,150
+27,431
| +738% | +$18M |
|
1614
CALL
Guardant Health
GH
$22.9B
| $23.1M | ﹤0.01% |
543,400
+128,400
| +31% | +$5.54M |
|
1615
Calumet Specialty Products
CLMT
$4.23B
| $23.1M | ﹤0.01% |
1,823,972
+305,392
| +20% | +$4.8M |
|
1616
Linde
LIN
$226B
| $23.1M | ﹤0.01% |
49,590
-236,300
| -83% | -$106M |
|
1617
CALL
Ciena
CIEN
$56.3B
| $23.1M | ﹤0.01% |
382,100
+95,700
| +33% | +$7.57M |
|
1618
CALL
Labcorp
LH
$27.3B
| $23.1M | ﹤0.01% |
99,200
-45,200
| -31% | -$11M |
|
1619
CALL
SBA Communications
SBAC
$19.7B
| $23.1M | ﹤0.01% |
104,800
-27,800
| -21% | -$5.82M |
|
1620
PUT
Monster Beverage
MNST
$94.3B
| $23M | ﹤0.01% |
787,200
+378,200
| +92% | +$9.86M |
|
1621
Interactive Brokers
IBKR
$43.7B
| $23M | ﹤0.01% |
555,072
-85,284
| -13% | -$4.23M |
|
1622
CALL
XP
XP
$9.1B
| $23M | ﹤0.01% |
1,671,000
+1,154,200
| +223% | +$15.9M |
|
1623
Hershey
HSY
$37.4B
| $22.9M | ﹤0.01% |
134,135
-228,595
| -63% | -$37.4M |
|
1624
PUT
Oxford Industries
OXM
$575M
| $22.9M | ﹤0.01% |
391,000
+328,500
| +526% | +$23.6M |
|
1625
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$296M
| $22.9M | ﹤0.01% |
680,856
+61,466
| +10% | +$2.18M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.